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Background and Significance: Deaths related to opioid overdose are increasing.  
Treatment for opioid use disorder (OUD) is necessary to help prevent future 
opioid abuse, and often involves opioid detoxification, followed by short-term 
residential treatment, typically lasting about 28 days.  Literature regarding OUD 
and short-term residential treatment is limited.  The purpose of this study was to 
determine predictors of short-term residential OUD treatment completion, and 
whether detoxification prior to entering residential treatment predicts residential 
treatment completion. 
Method: De-identified data regarding detoxification and short-term residential 
treatment was obtained from a Texas substance abuse treatment center.  A set 
of predictors from three domains of interest were assessed: demographics, social 
factors, and drug history factors.  Chi-square and Mann-Whitney U tests for 
categorical and continuous variables, respectively, were used to examine 
associations between independent variables and residential treatment 
completion.  The same tests were run between the primary independent variable 
of detoxification prior to residential treatment and the other independent 
variables.  Variables statistically significant for short-term residential completion 
and the primary independent variables were entered into binomial logistic 
regression models, assessing odds ratios of potential predictors of residential 
treatment completion. 
Results:  Of the total sample of 1001 patients, males were more likely to 
complete short-term residential treatment in both detoxification models tested    
 
 v  
(p = .001).  Full-time employment was 2.132 times more predictive of residential 
completion than was unemployment (p = .049).  Those reporting inhaled opioid 
abuse  were 2.342 times more likely to complete short-term residential treatment 
than those who injected opioids (p = .022).  Detoxification prior to residential 
treatment did not predict residential completion (Adjusted odds ratio = 1.302, p = 
.123).  For every day spent in detoxification, one was less likely to complete 
residential treatment (aOR = .960, p = .032).  Medicaid participants were less 
likely than those in a state-sponsored program to complete residential treatment 
in both detoxification models (p = .019 and p = .013). 
Conclusion: Health providers can reinforce that detoxification is not a cure for 
OUD, but a beginning of recovery. The use of medication-assisted treatment 
programs may be one option to improve treatment completion. 
 
Key words:  Opioid Use Disorder; Detoxification; Residential Treatment   
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Summary of Study 
 The proposal for this study was approved November 21, 2018, by the 
University of Texas Health Science Center at Houston.  Proposed demographics 
of interest were age, sex, race, level of education, area of residence, length of 
stay in treatment.  Proposed social factors included legal problems, living 
situation, and employment.  Drug history data was to include opioid of choice, 
route of drug administration, length of drug use, age of first use, as well as 
history of prior treatments.  Comorbid medical and psychiatric diagnoses were 
also proposed for examination.  Data regarding detoxification will be examined, 
to include length of detoxification, number of prior detoxifications, and specific 
opioid(s) of abuse.  Detoxification as a predictor of short-term residential 
treatment completion was also to be examined. 
Data regarding detoxification was to be examined, to include length of 
detoxification, number of prior detoxifications, and specific opioid(s) of abuse.   
Detoxification as a predictor of short-term residential treatment completion will 
also be examined. 
Modifications to the final study were necessitated due extensive 
missingness in the data set provided.  Specifically, no data was available 
regarding education, medical diagnoses, or psychiatric diagnoses (other than 
opioid use disorder diagnoses).  Data on living situations was also not available.  
Large amounts of missing data prevented using the variables of martial status 
and legal classification into the final regression equations. 
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Proposal Abstract 
In 2014, mortality from drug overdose surpassed motor vehicle accidents as 
the number one cause of accidental death in the United States (Rudd, Aleshire, 
Zibbell, & Gladden, 2016).  The current opioid epidemic has contributed to this 
new statistic.  Treatment opioid use disorder (OUD) is necessary to decrease 
further morbidity and mortality. 
Treatment for OUD often includes residential treatment centers (RTC) for the 
patient, consisting approximately 30 days.  Treatment may include initial 
detoxification, coupled with counseling and other forms of therapy (Substance 
Abuse and Mental Health Services Administration, 2017).  The purpose of this 
study is to determine predictors for completing residential treatment for OUD, and 
whether detoxification prior to entering RTC may also be factor in completing 
RTC.  The specific aims of this project include: 
1: To examine if demographics, social factors, drug history, and co-morbid 
diagnosis predict completion of a short-term residential treatment center; 
2: To investigate if there is a relationship between undergoing detoxification 
or not prior to entry into RTC that predicts completion of short-term residential 
treatment, and answer the hypothesis that necessity for OUD detoxification prior 
to RTC entry will predict poor RTC completion. 
Data from an RTC program in Texas (four different sites in total) will be 
examined.  Predictors of completion of RTC will be examined, including 
demographics, drug history, social factors, and co-morbidities.  Logistic 
regression will be used to examine whether these factors help predict RTC 
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completion.  Data from the corresponding detoxification centers at the four sites 
will be examined and compared to RTC completion to determine if there is a 
difference between those undergoing detoxification prior to RTC entry and those 
entering RTC directly. 
The significance of this project will help to provide further evidence for OUD 
for those in residential treatment. This study is innovative in that it seeks to 
examine predictors of RTC completion with and without prior detoxification, which 
may result in a clinical paradigm shift, as more specific interventions can be 
tailored to those with OUD.  
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Specific Aims 
 In 2014, mortality from drug overdose surpassed motor vehicle accidents as 
the number one cause of accidental death in the United States (Rudd, Aleshire, 
Zibbell, & Gladden, 2016).  The current opioid epidemic has contributed to this 
new statistic.  Treatment is key for those who are addicted to opioids.     
 Treatment for OUD often involves residential or inpatient treatment.  Short-
term residential treatment centers (RTC) typically includes a patient residing in 
the RTC community for about 30 days (SAMHSA, 2017).  Frequently treatment 
includes medically supervised detoxification coupled with counseling and an 
introduction to social support groups, such as Alcoholics Anonymous and 
Narcotics Anonymous.  Treatment may also consist of medication-assisted 
treatment, (MAT) (SAMHSA, 2016). 
 Several studies have been conducted examining drop-out from different 
treatment modalities, such as detoxification only, long-term therapeutic 
communities, and outpatient therapies (Brorson, Arnevik, Rand-Hendriksen, & 
Duckert, 2013).  However, few studies have examined predictors of completion in 
short-term treatment, representing a gap in the literature.  Therefore, there is a 
critical need to understand these predictors in order to develop interventions for 
this population.  The overall objective of this study is to determine predictors for 
completing RTC and to answer the question of what variables are related to 
completion of RTC among adult OUD patients that undergo medical 
detoxification prior to entering RTC and those not requiring detoxification upon 
RTC entry?   
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 The specific aims of this project are: 
1: To examine if demographics, social factors, drug history, and co-morbid 
diagnosis predict completion of a short-term residential treatment center.  
The hypothesis is that demographics, social factors, drug history, and co-
morbid diagnosis predict completion of a short-term residential treatment 
center. 
 - determining predictors of completion will provide data for providers that will 
assist to further tailor the treatment program to the individual. 
2: To investigate if there is a relationship between undergoing detoxification or 
not prior to entry into RTC that predicts completion of short-term 
residential treatment. The   hypothesis is that those who undergo OUD 
detoxification prior to RTC entry are less likely to complete short-term 
residential treatment than those who do not undergo OUD detoxification.  
 -determining whether undergoing detoxification for OUD helps or hinders 
one’s chances of completing residential treatment may help further tailor 
the treatment program to the individual. 
 This study is innovative in its approach in that it seeks to examine RTC 
completion for OUD and whether detoxification prior to RTC is a disadvantage for 
completing short-term residential treatment. 
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Significance 
 Overdose mortality is on the rise.  Death from heroin, synthetic opioids, 
cocaine and benzodiazepines overdoses have each increased (NIDA, 2017a; 
NIDA 2017b).  About 2.5 million visits to the emergency department involved 
drug or alcohol abuse or misuse (Substance Abuse and Mental Health Services 
Administration [SAMHSA], 2013).   
 Mortality from drug overdose (OD) has been increasing, particularly among 
opioid abusers.  Mortality from OD has increased from 2005 to 2015, from 29,813 
to 52,404 (NIDA, 2017a).  Heroin has seen a steep increase in OD deaths from 
just over 2,000 in 2010 to 15,446 deaths in 2016, equating to a six-fold increase 
over six years.  Synthetic opioids like fentanyl (other than methadone) have seen 
an even greater spike in OD deaths: 2013 witnessed around 3,000 deaths and 
over 20,000 in 2016 (NIDA, 2017b).  Treatment for OUD is necessary to help 
prevent relapse to opioid use and continued addiction to opioids, which in turn 
should help to decrease the number of opioid overdoses.    
Medically-Supervised Opioid Detoxification 
 Detoxification for opioid dependence often may be the first step in seeking 
treatment.  Medically-supervised detoxification typically includes the patient 
remaining in an inpatient facility and being monitored while the symptoms of 
withdrawal from the opioid are managed pharmacologically.  The patient may 
also undergo individual and group therapy during this phase of treatment.   
 Buprenorphine is an opioid receptor partial-agonist often used for 
dextoxification and maintenance of OUD recovery.   It has a strong affinity for 
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these receptors, making it difficult to be removed by other powerful opioid 
agonists such as heroin.  Buprenorphine is available in a single-drug sublingual 
tablet or, as a sublingual tablet or strip combined with the opioid antagonist, 
naloxone.  The naloxone portion acts as a prevention for abuse of the 
medication.  When taken sublingually, buprenorphine is able to provide its opioid 
effects, as naloxone does not work well when taken sublingually.  However, 
should the medication be tampered with, such as injecting the 
buprenorphine/naloxone combination, naloxone then becomes the dominant 
medication and will send the user into withdrawals (SAMHSA, 2016a).  
 By using buprenorphine as a replacement opioid, the patient is slowing 
weaned off the medication over a period of several days, depending on the 
individual’s severity of opioid abuse (Hakansson & Hallén, 2014). Buprenorphine 
was successfully used to transition 89% of participants from detoxification into a 
therapeutic community setting for continued therapy of their opioid addiction 
(Collins, Horton, Reinke, Amass, & Nunes 2007). When compared with a control 
group using clonidine for detoxification, buprenorphine was also associated with 
longer lengths of stay (mean 5.74 vs. 3.51 days) (Kovas, McFarland, McCarty, 
Boverman, & Thayer, 2007).Completion of the detoxification program was also 
higher with buprenorphine vs. clonidine (67 vs. 46 completions, respectively) 
(Kovas et al., 2007).  Typically buprenorphine, or the buprenorphine/naloxone 
combination, is started early in the detoxification process.  The patient is then 
slowly weaned off the medication over several days. 
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Short-Term Residential Treatment and Completion of RTC 
 Short-term residential treatment programs has long been a mainstay of 
treatment of substance use disorders.  Many programs are based on the 
Minnesota Model, which typically involves a 28-day stay for treatment . This may 
include individual counseling and group therapy (Henninger & Sung, 2014). 
 Several indicators have been suggested as predictors of success in 
substance use disorder (SUD) treatment, including demographics, history of drug 
use, and various comorbidities.  Dreifuss et al. (2013) found never having used 
heroin or extended-release oxycodone, and no prior treatments for opioid misuse 
were indicators of success (N = 360).  Males have been found to have higher 
lengths of success than females for treatment of opioid abuse in terms of 
detoxification completion (N = 126) (Ekhtiari, Dezfouli, Zamanian, Ghodousi, & 
Mokri, 2013).  Males also were found to have better retention in treatment for 
opioid use (N = 165) (Marsch et al., 2005).  Older age predicted success when 
defined as treatment retention at twelve months (N = 382) (Alford et al., 2011), 
survey and UDS results (Dreifuss et al., 2013), or successful detoxification 
(Ekhtiari et al., 2005).   
 Comorbidities of may include depression and antisocial personality. 
Depression at high levels appears to improve chances of success in treatment 
for cocaine and opioid misuse as measured by negative UDS (Marsch et al., 
2005) and retention (Dreifuss et al., 2013; Marsch et al., 2005). Antisocial 
personality has been implicated with poor treatment success, demonstrated by 
positive UDS for cocaine (Marsch et al., 2005). 
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 History of drug use may affect treatment success.  Success in detoxification 
was poor if heroin was the main drug of choice (Odds ratio [OR] = .25, p = .01) 
as well as longer duration of opioid misuse (OR = .89, p = .024), based on having 
negative UDS and last methadone daily dosage less than 15 mg as study 
measures (N=126) (Ekhtiari et al., 2013).  Using prescription opioids for euphoric 
effects only, as well as obtaining opioids from an illegitimate source, were also 
predictors of poor success in completing a 12-week stabilization program with 
buprenorphine/naloxone and a corresponding four-week taper (Dreifuss et al., 
2013).   
   RTCs frequently are used once a patient has completed detoxification 
treatment.  Typically lasting around 30 days, patients in RTC stay for further SUD 
treatment which includes counseling and introduction to social support groups, 
such as Alcoholics Anonymous or Narcotics Anonymous (Henninger & Sung, 
2014; SAMHSA, 2018).  RTC also appeared to enhance the likelihood of 
continued engagement in 12-step programs and improved coping skills in 
emerging adults (N = 292) (Schuman-Olivier, Greene, Bergman, & Kelly, 2014).  
Opioid users (n =1160) were found to have a length of stay in RTC that was 
approximately 2 days shorter (30.9 vs. 32.8 days) than non-opioid users (n = 
768)  (Bride et al., 2016).  Those experiencing a nonfatal opioid overdose were 
more likely to favor an RTC than other treatment options, including outpatient 
MAT (N = 485) (Stein et al., 2017). 
 Several studies have examined success at different types of clinical sites. 
Success in a primary care buprenorphine treatment program for OUD was 
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defined as program retention demonstrated by negative UDS testing for illicit 
drugs while still testing positive for buprenorphine, and attending required 
counseling appointments (Alford et al., 2011).  Primary care benzodiazepine 
detoxification success was measured as not receiving a benzodiazepine from the 
general practitioner in the follow-up period of 15 months (N = 170) (Voshaar et 
al., 2006).  Success in an outpatient therapy group for alcohol dependence was 
defined as attending all therapy sessions and abstaining from alcohol for 12 
weeks (N = 298) (Young et al., 2011).  Successful outpatient buprenorphine 
detoxification for OUD in youth aged 15-21 was defined as opiate-negative UDS 
at 12 weeks (N = 152) (Subramaniam et al., 2011).  Successful outpatient OUD 
detoxification with methadone was defined as negative UDS and retention in the 
program, as well as last daily methadone dosage of 15mg or less (Ekhtiari et al., 
2013).   
 Few studies have examined short-term RTC completion, as well as examining 
detoxification prior to RTC as a predictor of RTC completion.  Both of these 
factors indicate a gap in knowledge of treatment of OUD. It is imperative to have 
an understanding of predictors of completion, particularly in short-term residential 
treatment.  Predictors of completion in RTC may be different from those in other 
settings, necessitating alterations in treatment approaches.  This study will 
address this gap in knowledge by examining predictors of RTC completion so 
interventions can be developed to improve health outcomes as well as increase 
the potential for recovery in individuals with OUD. As there is a current opioid use 
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crisis in the U.S., knowledge of effective treatment is essential for these 
individuals.  
Conceptual Framework 
 This study is conceptually guided by Barker's Tidal Model of Mental Health 
Recovery (Buchanan-Barker & Barker, 2015).  The Tidal Model acknowledges 
that recovery is a process, with the healthcare provider helping OUD patients to 
discover their own path to recovery.  The model accepts that recovery is 
possible, and that the provider needs to be creative in approaching the patient's 
recovery (Young, 2010).  The idea of recovery is at the heart of overcoming any 
addiction (Alcoholics Anonymous, 2013; Narcotics Anonymous, 2018).  
 The Tidal Model emphasizes encouraging patients to learn what they can do 
in the face of a problem - in this case, opioid addiction. The premise of the Model 
is not to relieve patients of their addiction, but to allow them to find within 
themselves the means to deal with addiction, and thus live a productive life 
(Buchanan-Barker & Barker, 2015).  This is essential to recovery. Predictors of 
completion may mirror an individual’s lived experience.  Understanding the lived 
experience is also essential in promoting recovery (University of Birmingham, 
2008) 
Creativity in tailoring treatment to the individual is essential, and understanding 
predictors of completion will help nurses, counselors, physicians tailor care to 
such predictors present in an individual. 
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Innovation 
 Understanding those variables that do or do not predict completion of RTC is 
key. Understanding of variables that lead to RTC completion can assist with 
treatment modification.  This study is innovative in seeks to understand 
predictors of RTC completion and decrease the gap of knowledge regarding the 
linkage between medically supervised detoxification and completion of RTC for 
OUD.  This may result in a clinical paradigm shift, as more specific interventions 
can be tailored to those with OUD. 
Research Approach 
Design and Setting 
 The design of this study will be of a retrospective cohort study in the form of a 
record review of clients who received treatment for OUD from Cenikor 
Foundation. Cenikor provides treatment for substance use disorder in Texas and 
Louisiana.  The four short-term RTC locations are in Texas: Austin, Houston, 
Tyler, and Waco. 
Population, Sample, Sampling Procedures 
 Only those with any type of opioid as a primary drug of choice and who were 
clients of Cenikor's RTC from 2012 to July 2018 will be included.  Exclusion 
criteria will be individuals less than 18 years of age.  The population size will be 
fixed based on the data provided for each of the four RTC locations.   
 Cenikor will provide de-identified data from the four RTCs along with the 
corresponding detoxification data for analysis.  The study team will not know 
names of individuals.  The study protocol will be approved by the Committee for 
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the Protection of Human Subjects at the University of Texas Health Science 
Center at Houston (UTHSCH).   
Measurements 
 Specific aim 1  
 To examine if demographics, social factors, drug history, and co-morbid 
diagnoses predict completion of a short-term residential treatment center in those 
with OUD.  
 The hypothesis is that demographics, social factors, drug history, and co-
morbid diagnosis predict completion of a short-term residential treatment center. 
 Completion will be measured by indicating if participants finished the 28-day 
RTC program at Cenikor.  The Appendix illustrates the intake form utilized by 
Cenikor, providing demographic and other background information on the client.  
Demographic data to be collected will include age, sex, race, level of education, 
area of residence as determined by first two numbers of client's zip code, length 
of stay in treatment, and reason for discharge.   
 Social factors will include legal problems, living situation, and employment.  
Legal problems will be measured by participants answering “Yes” or “No” to a 
series of legal questions. For living situation, participants will check which of the 
following are true: adult living independently; homeless; jail; living with friends; 
single adult living with family; transient living situation; other. 
 Data on drug history will include type of opioid(s) used and subclassified into 
primary, secondary, tertiary drug of choice, where available.  Methods of drug 
administration, length of use, and age of first use will also be variables for drug 
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history. Prior history of treatment will also be examined, with number of prior 
treatments examined, where available.  
 Comorbid medical and psychiatric diagnoses will be measured by participants 
using a checklist of diagnoses as to whether they have ever been diagnosed with 
a specific disorder. Information regarding age of diagnosis and history will also 
be noted. 
 Specific aim 2 
 To investigate if there is a relationship between undergoing detoxification or 
not prior to entry into RTC that predicts completion of short-term residential 
treatment.  
 The hypothesis is that those who undergo OUD detoxification prior to RTC 
entry are less likely to complete short-term residential treatment than those who 
do not undergo OUD detoxification. 
 Data regarding detoxification will be examined, to include length of 
detoxification, number of prior detoxifications, and specific opioid(s) of abuse.  
Characteristics of those not continuing into RTC will be examined.  Detoxification 
as a predictor of RTC completion will also be examined. 
Data Analysis 
 Specific aim 1  
 To examine if demographics, social factors, drug history, and co-morbid 
diagnoses predict completion of a short-term residential treatment center in those 
with OUD.  
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 The hypothesis is that demographics, social factors, drug history, and co-
morbid diagnosis predict completion of a short-term residential treatment center. 
 Data provided from Cenikor's four RTC's will be transposed to SPSS for 
statistical analysis.  Using SPSS, descriptive statistics will be computed on all 
variables.  Data will be examined for outliers, as well as potential data errors.  
Data errors that are verifiable will be corrected; errors that cannot be verified will 
be coded as missing.  To determine correlation of continuous and binomial 
variables, correlation tables using Pearson’s correlation and Spearman's rank 
order coefficient (rho) will be generated.  Histograms will be generated for each 
continuous variable to determine normality.   
 Power analysis was computed using G-Power 3.0.10.  Based on a Chi 
Square with effect size of .3, alpha of .05, beta of .95, with one degree of 
freedom (based on completion of RTC with the nominal answers of yes or no), a 
total sample size for each treatment location was determined to be 145.   
 Generalized linear models will be generated with logistic regression.  
Categorical variables will be regressed against length of stay to determine if 
length of stay is predictable.  Length of use will also be regressed against LOS 
as well and RTC completion.  Survival analysis of time to drop-off will also be 
examined.  As data has already been collected, it is expected that the project will 
be completed in three to four months, with the majority of that timeframe spent on 
data translation to SPSS.   
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 Specific aim 2  
 To investigate if there is a relationship between undergoing detoxification or 
not prior to entry into RTC that predicts completion of short-term residential 
treatment.  
 The hypothesis is that those who undergo OUD detoxification prior to RTC 
entry are less likely to complete short-term residential treatment than those who 
do not undergo OUD detoxification. 
 Data provided from Cenikor's four RTCs’ corresponding detoxification 
facilities will be transposed to SPSS for statistical analysis.  Using SPSS, 
descriptive statistics will be computed on all variables.  Data will be examined for 
outliers, as well as potential data errors.  Data errors that are verifiable will be 
corrected; errors that cannot be verified will be coded as missing.  To determine 
correlation of continuous and binomial variables, correlation tables using 
Pearson’s correlation and Spearman's rank order coefficient (rho) will be 
generated.  Histograms will be generated for each continuous variable to 
determine normality.   
 Logistic regression will be utilized to examine whether detoxification is 
predictive of completion of RTC, as well as number of prior detoxifications.  
Differences between those who completed detoxification prior to RTC and those 
entering directly into RTC will also be examined. 
Study Limitations 
 The main risk of this project is managing the confidentiality of the data 
provided by Cenikor.  The data will be de-identified by Cenikor before it will be 
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given to the PI.  However, the data set is expected to be large, and the potential 
for identifying data being passed on does exist.  In such circumstances, Cenikor 
will be made aware of the identifiable data.  Such instances will be excluded from 
the study. 
Human Subjects 
 Risks to the individual clients will be quite minimal, as all data will be de-
identified by Cenikor prior to release to the study team.  Individual clients will only 
be identified by a code.  All data will be stored on a password-protected flash 
drive to also ensure data privacy.  At the end of the study, all data will be 
destroyed and any papers containing data will be shredded. 
 Benefits will include a better understanding of predictors of RTC completion 
regarding whether detoxification was necessary or not. Such knowledge would 
be helpful in tailoring an individual's treatment program to increase the likelihood 
of RTC completion. 
Timeline 
 As data have already been collected, the length of time for this project is 
expected to be about two to three months.  The majority of time spent on this 
project will involve examining the de-identified data provided by Cenikor and 
"cleaning" the data so that it may be used in an SPSS format, which perhaps 
may take up to three to four months.  Once examined in SPSS, the results will be 
interpreted, and a written analysis of the findings will be produced. 
 
 
    19 
 
Budget 
 Since data have already been collected, and the primary investigator (PI) 
leases SPSS for concurrent schoolwork with UTHSCH Cizik School of Nursing, 
no other budgetary needs are anticipated.  A security-coded flash drive will be 
used to store all data and material for this project and will be maintained by the 
PI. 
Facilities & Other Resources 
The University of Texas Health Science Center at Houston 
Established in 1972 by The University of Texas System Board of Regents, 
The University of Texas Health Science Center at Houston (UTHealth) is 
Houston’s Health University and Texas’ resource for health care education, 
innovation, scientific discovery and excellence in patient care. The most 
comprehensive academic health center in The UT System and the U.S. Gulf 
Coast region, UTHealth is home to schools of biomedical informatics, biomedical 
sciences, dentistry, nursing and public health and the John P. and Kathrine G. 
McGovern Medical School.  UTHealth includes The University of Texas Harris 
County Psychiatric Center and a growing network of clinics throughout the 
region. The university’s primary teaching hospitals include Memorial Hermann-
Texas Medical Center, Children’s Memorial Hermann Hospital and Harris Health 
Lyndon B. Johnson Hospital. 
UTHealth Cizik School of Nursing 
 The University of Texas Health Science Center at Houston (UTHealth) Jane 
and Robert Cizik School of Nursing, established in 1890 as part of the John 
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Sealy Hospital Training School for Nurses in Galveston, is one of the oldest 
schools of nursing in the southwestern United States. The baccalaureate nursing 
program of the UT System expanded to Houston in 1972, the same year that the 
UT Health Science Center came into being. The Cizik School of Nursing was 
organized in 1972 and began offering the master of nursing degree in the same 
year. In 1976, the system structure dissolved and the School of Nursing was 
reorganized under the control of the health science center. The School initiated 
the Doctor of Science in Nursing degree program in 1995 (changed to the PhD in 
Nursing in 2007) and the Doctor of Nursing Practice degree program in 2006.  
Cizik School of Nursing is ranked in the top five percent of graduate nursing 
programs in the country, according to the latest survey results by U.S. News and 
World Report. The School of Nursing is one of six academic units of UTHealth, 
which is a component health institution of The University of Texas System. The 
other UTHealth units, in chronological order of operation, are: School of Dentistry 
(1905), Graduate School of Biomedical Sciences (1963), School of Public Health 
(1967), Medical School (1970), and School of Biomedical Informatics (2000). The 
campus is located in the world-famous Texas Medical Center, where students 
enjoy the resources of a distinguished health science center combined with the 
expertise and inter-disciplinary collaborative opportunities of the world's largest 
medical center.  Faculty members hold joint appointments at the Medical School, 
School of Public Health, School of Biomedical Informatics, and many Houston-
area hospitals and health care agencies, including the UT MD Anderson Cancer 
Center. 
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Cenikor Foundation 
 The Cenikor Foundation is a not- for- profit, CARF accredited, organization 
that provides substance abuse services to adolescents & adults. Cenikor 
provides four  treatment options for clients struggling with their addiction: Detox 
programs, Residential Treatment, Intensive Outpatient programs and long term 
Therapeutic Communities. Cenikor offers evidenced-based treatment and 
accredited programming, within a credentialed infrastructure, with the support of 
licensed clinical staff to support men, women and adolescents on their individual 
path to recovery. With a continuum of care, clients have the opportunity to seek 
the program that best suits their immediate needs and to move into other 
programs as their need changes. Cenikor is dedicated to finding the right level of 
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Predictors of Short-term Residential Treatment Completion  
Preceded by Detoxification for Opioid Use Disorder 
Introduction 
 Mortality rates from opioid overdose are on the rise.  Mortality from opioid 
overdose increased from 29,813 in 2005  to 52,404 in 2015 (National Institute on 
Drug Abuse [NIDA], 2017a).  Heroin has seen a steep increase in overdose 
deaths from just over 2,000 in 2010 to 15,446 deaths in 2016, equating to a six-
fold increase over six years.  Synthetic opioids such as fentanyl (other than 
methadone) have seen an even greater spike in overdose deaths.  In 2013 there 
were approximately 3,000 deaths and over 20,000 in 2016 (NIDA, 2017b).  
Treatment is necessary to help prevent relapse and promote remission for 
people with opioid use disorder (OUD). This in turn should lead to a decrease in 
the number of opioid overdoses.    
Medically-Supervised Opioid Detoxification 
 Detoxification for OUD is often the first step for patients seeking treatment.  
Medically-supervised detoxification typically includes an inpatient hospitalization 
and  monitoring while the symptoms of opioid withdrawal are managed 
pharmacologically (Kleber, 2007).  The patient may also undergo individual and 
group therapy during this phase of treatment (Kleber, 2007). 
  Opioid detoxification often involves giving patients opioid replacement 
medications, such as buprenorphine.  Patients in this treatment are slowly 
weaned off the medication over a period of several days, depending on the 
severity of withdrawal symptoms experienced (Hakansson & Hallén, 2014).  
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Although buprenorphine was the medication used for detoxification in the current 
study, the medication was not continued into short-term residential treatment as 
a form of medication-assisted treatment (MAT).  
Predictors of Outcome in Substance Use Disorder Treatment  
 Several variables have been suggested as predictors of OUD treatment 
outcome, including demographics and history of drug use.  Dreifuss et al. (2013) 
found that never having used heroin or extended-release oxycodone, and no 
history of prior treatment for opioid misuse predicted success, defined as 
negative urine drug screen, in a sample of 360 participants with OUD.  Longer 
lengths of opioid misuse prior to treatment were more likely to continue to misuse 
when compared to those with lower levels of misuse (Brewer, Catalano, 
Haggerty, Gainey, & Fleming, 1998).  Patients with repeated detoxifications were 
less likely to pursue further treatment (Carrier et al., 2011).  Patients attending 
rehabilitation only had a longer average length of stay in treatment compared to 
those requiring detoxification before rehabilitation (Blanchard et al., 2019),  
 In terms of gender, males have been found to complete OUD detoxification 
more frequently than females. (N = 126) (Ekhtiari, Dezfouli, Zamanian, Ghodousi, 
& Mokri, 2013).  Males were also found to have better retention in OUD treatment 
than females (N = 165) (Marsch et al., 2005).  Older age predicted success when 
defined as treatment retention at twelve months (N = 382) (Alford et al., 2011), 
survey and urine drug screen results (Dreifuss et al., 2013), or successful 
detoxification (Ekhtiari et al., 2005).     
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 History of drug use may also affect treatment outcomes.  Outcome in 
detoxification was poor if heroin was the main drug of choice (Odds ratio [OR] = 
.25, p = .01) or if the opioid use was of a longer duration. (OR = .89, p = .024), 
This was based on having a negative urine drug screen and last methadone daily 
dosage less than 15 mg as study measures (N = 126) (Ekhtiari et al., 2013).  
Having used prescription opioids for euphoric effects only or obtaining opioids 
from an illegitimate source, were also predictors of poor outcomes in completing 
a 12-week stabilization program with buprenorphine/naloxone and a 
corresponding four-week taper (Dreifuss et al., 2013).   
  Several studies have examined the definitions of treatment completion  at 
different types of clinical sites.  Successful completion in a primary care 
buprenorphine treatment program for OUD was defined by negative urine drug 
screen testing for illicit drugs (other than buprenorphine) and attending required 
counseling appointments (Alford et al., 2011).  Primary care benzodiazepine 
detoxification completion was defined as not receiving a benzodiazepine from the 
general practitioner in the follow-up period of 15 months (N = 170) (Voshaar et 
al., 2006).  Attendance at all therapy sessions and abstaining from alcohol for 12 
weeks (N = 298) (Young et al., 2011) defined success in an outpatient therapy 
group for alcohol dependence.  Completion of outpatient buprenorphine 
detoxification for OUD in youth aged 15-21 years old was defined as opiate-
negative urine drug screen at 12 weeks (N = 152) (Subramaniam et al., 2011).  
The definition of successful outpatient OUD detoxification with methadone was a 
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negative urine drug screen and retention in the program, as well as last daily 
methadone dosage of 15mg or less (Ekhtiari et al., 2013).   
Short-Term Residential Treatment 
 Short-term residential treatment programs have long been a mainstay of 
treatment of substance use disorders and frequently are used once a patient has 
completed detoxification treatment.  Patients in short-term residential treatment 
stay for approximately 30 days, receiving further substance use disorder 
treatment which includes counseling and introduction to mutual support groups, 
such as Alcoholics Anonymous or Narcotics Anonymous (Henninger & Sung, 
2014; SAMHSA, 2018).  Short-term residential treatment was found to enhance 
the likelihood of continued engagement in 12-step programs and improve coping 
skills in emerging adults aged 18 to 25 years (N = 292) (Schuman-Olivier, 
Greene, Bergman, & Kelly, 2014).  Patients with OUD (n =1160) were found to 
have a length of stay in short-term residential treatment that was approximately 2 
days shorter (30.9 vs. 32.8 days) than those who did not use opioids (n = 768)  
(Bride et al., 2016).  People experiencing an opioid overdose were more likely to 
favor a short-term residential treatment than other treatment options, including 
outpatient medication-assisted treatment (N = 485) (Stein et al., 2017). 
 Employment is a form of recovery capital, representing a strength in 
maintaining recovery for the long-term.  Employment recovery capital has been 
shown to predict successful completion (defined as reported abstinence at six 
months post-treatment) across various methods of substance use disorder 
treatment, including as residential treatment and intensive outpatient (Sahker, Ali, 
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& Arndt, 2019). Employment has also been shown to be related to a cessation or 
a decreased use of heroin (Hser, Evans, Grella, Ling, and Anglin, 2015). 
  Few studies have examined short-term residential treatment completion, as 
well as examining detoxification prior to short-term residential treatment as a 
predictor of short-term residential completion for OUD.  It is imperative to have an 
understanding of predictors of completion, particularly in short-term residential 
treatment, as these predictors of may be different from those in other treatment 
settings, necessitating alterations in treatment approaches.   
 The current study addresses this gap in knowledge by examining predictors 
of short-term residential treatment completion as a first step to developing and 
testing interventions that can improve health outcomes as well as increase the 
potential for remission and recovery in individuals with OUD. As there is a current 
opioid use crisis in the U.S., knowledge of effective treatment is essential for 
these individuals.  
 Based on previous studies, expected predictors of short-term residential 
completion include males (Ekhtiari et al., 2013; Marsch et al., 2005) and older 
age (Alford et al., 2001), and employment (Sahker, Ali, & Arndt, 2019).  Heroin 
use (Ekhtiari et al., 2013) and higher frequency of use (Brewer et al., 1998) 
would not be predictive of completion.  In regards to completion of short-term 
residential treatment preceded by detoxification, it was expected that 
detoxification would not be predictive of short-term residential treatment 
completion (Blanchard et al., 2019; Carrier et al., 2011). 
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   The specific aims and hypotheses of this study were to: (1) Examine if 
demographics, social factors, and drug history predict completion of a short-term 
residential treatment center. It was hypothesized that male gender, older age, 
and being employed would be predictive of short-term residential treatment 
completion, while opioids stronger than or equal to morphine, and higher 
frequency of opioid misuse would not be predictive of completion; and (2) 
investigate whether there is a relationship between undergoing detoxification or 
not prior to entry into short-term residential treatment. It was hypothesized that 
individuals who undergo OUD detoxification prior to short-term residential 
treatment entry are less likely to complete short-term residential treatment than 
those who do not undergo OUD detoxification. 
Methods 
Design and Setting 
 The design of this study was a retrospective cohort study. Data was obtained 
from  a review of client’s records who received OUD treatment in a substance 
abuse disorder treatment organization located in Texas. This organization 
operates four short-term residential treatment programs for adults at four 
locations: Central Texas (sites 1 and 3), one in Northeast Texas (site 2), and 
Southeast Texas (site 4). 
Population and Sampling Procedures 
 Adults with a diagnosis of OUD and who participated in one of the four short-
term residential treatment programs from July 2014 to December 2018 were 
included.  Individuals less than 18 years of age were excluded.  The population 
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size was determined by the data provided by each of the four treatment 
locations.  De-identified data extracted from the client records and corresponding 
detoxification data was provided by the organization’s four short-term residential 
treatment sites.  The study protocol was approved by the Committee for the 
Protection of Human Subjects at the University of Texas Health Science Center 
at Houston.   
Measurements 
 Appendix A illustrates the intake form utilized by the treatment organization, 
providing demographic and other  information on the client.  Demographic data 
collected included age, sex, religion, marital status, race, veteran status, type of 
insurance/payment, and area of residence as determined by first three numbers 
of the patient's zip code. 
 Social factors included employment and legal problems classification.  Legal 
problems were classified based on a multilevel categorical independent variable, 
including walk-ins, parole, probation, legally suggested referral, and court 
mandated.  Levels of employment included unemployed, employed full-time, and 
employed part-time.  
 Data on drug use history and primary opioid of choice were examined.  The 
opioid of choice variable was categorized based on relative strength using 
morphine milligram equivalents (MME) as recommended by the State of Ohio 
Board of Pharmacy (2017).  MME levels included (a) MME stronger than 
morphine (buprenorphine, fentanyl, hydromorphone, methadone, and 
oxycodone); (b) MME equal to morphine (morphine and hydrocodone); and (c) 
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MME weaker than morphine (codeine, tramadol, and others).  Heroin was kept 
as a separate level due to its illegal status.  Routes of drug administration, 
frequency of use in the last 30 days, and age of first use were also variables of 
interest for drug history.  Prior history of treatment was also examined by the 
number of prior treatments, whether those treatments were completed or not. 
 To accommodate the large range of abbreviated first 3-digit zip codes 
represented in this study, the codes were condensed to geographic regions: 
Austin Area, Dallas/Ft. Worth Area, Houston Area, North and West Texas, 
Northeast Texas, San Antonio/South Texas, Waco Area, and Outside Texas. 
  Completion of short-term residential treatment was defined as staying in 
the program for 28 days, or as deemed by the organization’s clinical staff as 
having reached completion goals.  Data examined regarding residential 
treatment completion  included length of stay in detoxification, number of prior 
treatment episodes, and specific opioid of choice.  Detoxification as a predictor of 
short-term residential treatment completion was the primary independent variable 
of interest, and was examined first as a dichotomous (yes or no) variable, and 
then as a continuous variable by length of stay in detoxification.  This was to 
address possible collinearity between the two primary independent variables of 
interest. 
Data Analysis 
 Data provided from the organization’s four treatment sites were transposed to 
the Statistical Package for the Social Sciences (SPSS, version 24), for statistical 
analysis.  Descriptive statistics were computed on all variables. Verifiable data 
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errors were corrected; errors that could not be verified were coded as missing.    
Chi-square and Mann-Whitney U tests were calculated to determine statistically 
significant association between the dependent variables and independent 
variables.  Significant variables were to be entered into the binomial logistic 
regression analyses.  To determine association of continuous and binomial 
variables, Mann-Whitney U tests were conducted on continuous independent 
variables and both the dichotomous dependent variable of short-term residential 
treatment completion and the primary independent variable of detoxification 
before short-term residential treatment.  Pearson’s Chi-square was calculated for 
all categorical independent variables and the dependent variable.  
 Power analysis was computed using G-Power 3.0.10 (Faul, Erdfelder, Lang, 
& Buchner, 2007).  Based on a Chi-square with effect size of .3, alpha of .05, 
beta of .95, with one degree of freedom (based on completion of short-term 
residential treatment with the nominal answers of yes or no), a total sample size 
for each treatment location was determined to be 145.   
  Data from the combined treatment sites were used to assess odds ratios 
for each separate independent variable using binary logistic regression for the 
dependent variable.  Odds ratios were adjusted by adding the other statistically 
significant independent variable identified by Chi-square and Mann-Whitney U 
results into the binary logistic regressions.  Patient age and variables that were 
not significant, but related to history of drug use, were also added to the 
regression to examine drug use history.   
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 Separate binary logistic regressions were run for the dependent variable of 
completion of short-term residential treatment and the primary independent 
variables.  One regression examined the dichotomous primary independent 
variable of detoxification prior to short-term residential treatment (yes or no), as 
well as variables with statistically significant Mann-Whitney or Chi-Square results 
for both the dependent variable and primary independent variables  The second 
regression replaced the dichotomous detoxification variable with the continuous 
primary independent variable of length of stay in detoxification, while keeping the 
previously mentioned significant independent variables.  This was to examine if 
length of stay in detoxification affected short-term residential treatment 
completion 
 The dichotomous primary independent variable of detoxification prior to short-
term residential treatment was examined as a predictor of completion of short-
term residential treatment.  Detoxification length of stay was separately 
regressed against the dependent variable (without the dichotomous detoxification 
variable) to see if the continuous variable yielded different results in regards to 
short-term residential completion. 
Results 
 The total study population was 1001. The sample sizes for sites 3 and 4 (n = 
181 and n = 169, respectively) were smaller than sites 1 and 2 (n = 423 and n = 
228, respectively).  The average age was 36.06 years, while the average age of 
first opioid use was 24.35 years.  Males accounted for 57.5% of the sample.  
Seven hundred forty-four clients underwent detoxification.   The average length 
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of stay in short-term residential treatment was 16.85 days, while the average 
length of stay in detoxification was 5.37 days.  The average number of prior 
treatment episodes was 0.16.  Heroin was the most frequent opioid of choice (n= 
514) and intravenous injection the most common form of drug use (45.6%).  The 
Houston, Texas area was the most common area of residence (22.00%).  
Frequencies of demographics and other variables may be found in Table 1.  
Several cases (n = 239) had larger amounts of missing data, particularly for 
Legal Classification and Marital Status, as well as specific drug use data, 
requiring those cases to be excluded from the study prior to statistical testing, 
resulting in the total population size of 1001.  
Specific Aim One 
 For specific aim one, it was hypothesized that demographics, social factors, 
and drug use history would predict completion of short-term residential treatment. 
Mann-Whitney U tests were conducted for the continuous independent variables 
and the dependent variable of short-term residential treatment completion. The 
same tests were run for the primary independent variable of detoxification prior to 
short-term residential treatment (Table 2).  Length of stay in detoxification was 
statistically significant in relation to completion of short-term residential treatment 
(p < .001), as was detoxification prior to short-term residential treatment (p < 
.001; Table 2).  Frequency of use during the last 30 days was also significantly 
associated in relation to both short-term residential completion and detoxification 
prior to short-term treatment  (p = .005 and p < .001, respectively). 
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 Chi-square tests were performed to examine associations between the 
categorical independent variables and the dependent variable of short-term 
residential completion and the dichotomous primary independent variable of 
detoxification prior to short-term residential treatment (Table 3).  Treatment 
Location (p = .024), Gender (p = .001), Route of Administration (p = .035), Opioid 
of Choice (p = .041), and Employment Status (p = .014) emerged as significant 
predictors.  Treatment Location (p < .001), Opioid of Choice (p = .013), Legal 
Classification (p = .011), Payer Type (p < .001), and Geographic Location (p = 
.025) were significantly associated with detox prior to residential treatment.  
Although Legal Classification was significant, it was not entered into the 
regression due to the large amount of missing data (n = 365, or 36.5%). 
  Each statistically significant variable was examined for odds ratios (OR) and 
adjusted odds ratios (aOR) for short-term residential treatment completion (Table 
4).  Those treated at Site 2 were 1.497 (aOR) times more likely to complete 
short-term residential treatment (p = .041) than those at Site 1.  Clients at site 3 
were 2.967 times more likely to not complete short-term residential treatment 
when compared to those from Site 1 (aOR = .337, p = .042).  
 Males were 1.689 times (aOR) times more likely to complete short-term 
residential treatment than females (p = .002).  Those who inhaled  opioids was 
2.342 times (aOR) more likely to complete short-term residential treatment 
compared to those using intravenous injection (p = .022).  Those that were 
employed full-time were more than twice as likely to complete short-term 
residential treatment compared to those who were unemployed (aOR = 2.231, p 
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= .049).  Frequency of opioid use over the 30 days prior to entering treatment 
was not statistically significant for completion of short-term residential treatment 
(p = .051). 
Specific Aim Two 
 For specific aim two, it was hypothesized that individuals who undergo OUD 
detoxification prior to short-term residential treatment entry are less likely to 
complete short-term residential treatment than those who do not undergo OUD 
detoxification.  This was examined with prior detoxification as a dichotomous 
variable, and then as a continuous variable in the form of length of stay in 
detoxification as the primary independent variable. 
 Detoxification prior to short-term residential treatment as main predictor 
 Referring to Table 5, detoxification prior to short-term residential treatment 
yielded an OR 1.402 (p = .022), indicating that those who did not undergo 
detoxification prior to short-term residential treatment were more likely to 
complete; however, the aOR of 1.302 for the same primary independent variable 
was not significant (p = .123).  Males were 1.556 (aOR) times more likely to 
complete short-term residential treatment (p = .001).  Those using Medicaid as a 
primary method to pay for treatment had an aOR of .516 (p = .019), translating to 
being 1.938 times more likely to not complete short-term residential treatment 
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 Detoxification length of stay as main predictor    
 For every day in detoxification, a client was 1.042 times more likely to not 
complete short-term residential treatment (aOR = .960, p = .032).  Males were 
1.554 times more likely to complete short-term residential treatment (p = .001).  
Those using Medicaid had an aOR of .496 for completing short-term residential 
treatment (p = .013).   
Discussion 
 This study found that males, full-time employment, and nasal use of opioids 
were predictors of  short-term residential treatment completion.  Those treated at 
Site 2 were more likely to complete short-term residential treatment, while those 
at Site 3 were less likely to complete residential treatment for OUD.  Frequency 
of use during prior to entering treatment was not statistically significant to short-
term residential treatment completion. Detoxification prior to short-term treatment 
did not predict completion of short-term residential treatment for OUD, supporting 
the second hypothesis. 
 Results from this study found that the more days individuals spent in 
detoxification for OUD, the less likely they were to complete short-term 
residential treatment.  This may arise  from a belief that one is “cured” once the 
detoxification process is complete.  Kleber (2007) noted that therapists reported 
many patients taking buprenorphine or methadone for maintenance of OUD may 
refuse counseling due to their feeling of wellness.  Fifty-two per cent of OUD 
clients using extended-release naltrexone patients “felt cured,” and opted to 
discontinue the treatment (Williams et al., 2017).  These sentiments may be 
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similar for not completing short-term residential treatment.  Other possibilities 
include lack of funding to continue short-term residential treatment, or insurance 
cutting off funding at a given number of days in short-term residential treatment.  
Stein et al. (2017) found that only 11% of those completing detoxification 
preferred short-term residential treatment, while a majority preferred outpatient 
medication-assisted treatment.  The current findings suggest the use of 
medication-assisted treatment into short-term residential treatment, as this may 
allow the patient to help fight cravings for opioids (U.S. Department of Health and 
Human Services, Office of the Surgeon General [HHS], 2018), and thus remain 
in treatment for a longer length of time. 
 Treatment Site 2 demonstrated a higher odds ratio for completing short-term 
residential treatment compared to Site 1.  One possibility is that heroin was not 
the most frequently reported opioid of choice; rather, opioids with an MME equal 
to morphine were more frequently reported, which included hydrocodone.  
 Those using nasal inhalation of opioids demonstrated better chances of 
completing short-term residential treatment when compared to those using 
intravenous injections of drugs.  This was an interesting finding, but may be due 
to the lower number of those reporting nasal usage (n = 76 compared to n = 744 
for intravenous injection).  Frequency of opioid use in the last 30 days was not 
statistically  significant for the model of demographics and drug use (aOR = .984, 
p = .051).  The same was true in the other regressions examined with the primary 
independent variable of detoxification before short-term residential treatment (p = 
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.180), as well as for the primary independent variable of length of stay in 
detoxification (p = .260).   
 Older age was not statistically significant for completion of short-term 
residential treatment; this is in contrast to others studies that found improved 
retention with older age (Alford et al., 2011; Dreifuss et al., 2013; Ekhtiari et al., 
2005).  Males were more likely to complete short-term residential treatment for 
OUD.  Barriers for women and OUD treatment may include economic difficulties, 
family responsibilities, and feelings of shame (Green, 2006).     
 Being employed full-time demonstrated a higher aOR for completing short-
term residential treatment when compared to those who were unemployed.  This 
is consistent with Hser et al. (2015), who suggest employment helps provide 
structure to those in recovery.  Type of vocation was not examined in this study, 
but may be of interest for future research.  Employment may also allow one to 
afford health insurance, although commercial insurance or private pay did not 
figure significantly with short-term residential treatment completion with either 
primary independent variable (Table 5).  Employment recovery capital has been 
shown to predict treatment completion, particularly when there is an improvement 
in employment recovery capital (Sahker et al., 2019).  Those using Medicaid 
were 1.94 times less likely to complete short-term residential treatment 
(dichotomous primary independent variable aOR = .516 for short-term residential 
treatment completion, p = .019) than those in a state-sponsored program.  This 
was also true for the continuous primary independent variable of length of stay in 
detoxification (aOR = .496, p = .013). 
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Limitations 
 Limitations to this study involve the available data set.  The sample sizes for 
sites 3 and 4 were smaller than sites 1 and 2, possibly owing to the fact that sites 
3 and 4 are the most recent additions to the organization’s short-term residential 
treatment locations in Texas, and therefore fewer clients.  As this study was 
retrospective in nature, data was limited to what had been entered into the data 
base.  Since the data had been de-identified, it was not possible to speak with 
specific clients to verify missing data, particularly for the variables of Legal 
Classification and Marital Status.   
 Missing data for legal status and marital status prevented those variables 
from being entered into the regression equation by SPSS; this was part of the 
reason for only examine the combined sites population and not each site 
individually.  Logistic regression requires larger sample sizes to provide reliable 
results (Leech, Barrett, & Morgan, 2015); site 3 and 4 had smaller populations (n 
= 181 and n = 169, respectively).  The sample sizes themselves were adequate 
for regressions, but when cases with missing data were removed by SPSS, the 
resulting sample sizes were inadequate for reliable regression results. 
Implications for Practice and Research  
 The findings from this study raise implications for practice and future 
research.  Knowing that detoxification does not predict that one will complete 
short-term residential treatment, addiction specialists should find ways of 
reinforcing that detoxification is not a cure for OUD, but merely a beginning on 
the road to recovery.  The feeling of being cured once withdrawal symptoms 
PREDICTORS OF SHORT-TERM RESIDENTIAL 51 
 
have subsided presents a difficult barrier to overcome for continued OUD 
recovery.   
 Future research should assess the differences among different treatment 
locations in clients’ completion of short-term residential treatment .  Site 2 
exhibited higher odds ratios of residential completion, when compared to Site 1; 
Site 3 subjects demonstrated lower odds rations of residential completion.  
Assessing specific predictors for each location may help tailor treatment plans for 
clients at each treatment location. 
 Further research examining factors related to gender and completion of short-
term residential treatment would also be of interest, including links to 
socioeconomic factors.  This may also be extended to full-time employment 
being predictive of completion of short-term residential treatment, which may 
influence what time of insurance or payment program is utilized.  Having 
Medicaid was also not predictive of short-term residential treatment completion in 
this study.  Further investigation into the relationship between gender, 
employment status, and Medicaid should be examined, which may help in 
developing interventions for completion of short-term residential treatment. 
 The treatment organization in the current study did not utilize medication-
assisted treatment during short-term residential treatment.  The United States 
Surgeon General recent recognized medication-assisted treatment, along with 
other rehabilitation services, as the gold-standard for treating OUD (HHS, 2018).  
Use of medication-assisted treatment, however, may be blunted by certain 
philosophical beliefs regarding treatment and recovery.  Barriers to medication-
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assisted treatment include insufficient training, lack of institutional support, lack of 
support by clinician peers, provider bias, and regulatory requirements (Haffajee, 
Bohnert, & Lagisetty, 2018).  It would be of interest to repeat the current study,  
but with the addition of medication-assisted treatment, such as buprenorphine. 
Conclusions 
 This study found that detoxification prior to short-term residential treatment 
does not enhance one’s chance of completing short-term residential treatment.  
This may be due to one’s belief of being cured once one undergoes 
detoxification.  Clients with Medicaid were not as likely to complete short-term 
residential treatment, which is an aspect that bears further investigation.  Nasal 
inhalation of opioids predicted successful completion of short-term residential 
treatment.  Further investigation into route of administration may be of use, as 
well as the influence of gender and full-time employment on short-term 
residential treatment completion.  Understanding that detoxification prior to short-
term residential treatment does not predict completion of residential treatment 
may be useful in helping addiction specialists in promoting continuation of care 
for opioid use disorder recovery.  
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Table 1 
Demographics and Frequencies 
 Combined 
Sites 
N = 1001 
Site No. 1 
N = 423 
Site No. 2 
N = 228 
Site No. 3 
N = 181 
Site No. 4 
N = 169 
Age in Years (mean) 36.06 35.56 36.43 35.40 37.50 
Detox LOS  
(days, mean) 
5.37 5.13 4.54 5.48 6.98 
STR LOS  
(days, mean) 
16.85 17.56 15.46 17.76 14.82 












# of Prior Treatments 
(mean) 
.16 .09 .13 .22 .27 
Age First Use, Years 
(mean) 
24.35 23.86 24.78 23.24 26.10 
Male (%) 576  (58%) 246 (52%) 134 (59%) 101  (56%) 95 (56%) 
STR Completion? (%) 538 (54%) 222 (52%) 142 (62%) 92 (51%) 82 (49%) 












Race – African 
American, Not 
Hispanic 
69 (7%) 27  (6%) 14 (6.1%) 8 (4%) 20 (12%) 
Race – American 
Indian/Native 
American 
 7 (.7%) 6 (1%) 1 (.4%) 0 3 (2%) 
Race – Other 10 (1%) 3 (.7%) 1 (.4%) 3 (2%) 0 
Race – Bi-Racial 11 (1%) 3 (.7%) 1 (.4%) 2 (1%) 5 (3%) 






















Route- Oral 439 (44%) 191 (45%) 123 (54%) 49 (27%) 76 (45%) 
Route – IV Injection 457 (46%) 190 (45% 79 (35%) 117 (65%) 71 (42%) 
Route – Nasal 76 (8%) 32 (8%) 17 (8%) 8 (4%) 19 (11%) 
Route – Smoking 22 (2%) 8 (1.9%) 6 (3%) 5 (3%) 3 (2%) 
OOC – Heroin  514 (51%) 214 (51%) 89 (39%) 127 (70%) 86 (51%) 
























OOC – Weaker than 
Morphine (MME) 
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Table 1 – continued 
Demographics and Frequencies 
 Combined 
Sites 
N = 1001 
Site No. 1 
N = 423 
Site No. 2 
N = 228 
Site No. 3 
N = 181 
Site No. 4 





















0 1  
(.6%) 



























































Veteran - Yes 10 (1%) 4 (1%) 2(.9%) 1(.6%) 3 (2%) 
Veteran  - No 991 (99%) 419 (99%) 226 (99%) 180 (99%) 166 (98%) 
Unemployed 594 (59%) 371 (88%) 158 (69%) 21 (12%) 44 (26%) 
Employed Full-time 42 (4%) 21 (2%) 20 (9%) a 1 (.6%) 
Employed Part-time 10 (1%) 6 (1%) 3 (1%) a 1(.6%) 
Religion – Protestant 207 (21%) 80 (8%) 58 (25%) 30 (17%) 39 (23%) 
Religion – Other 118 (12%) 28 (7%) 25 (11%) 30 (17%) 35 (21%) 
Religion – Catholic 31 (3%) 5 (2%) 6 (3%) 9 (5%) 11 (7%) 
Religion – Agnostic 10 (1%) 1 (.2%) 8 (4%) 1 (.6%) 0 
Religion – None 131 (13%) 19 (4%) 20 (9%) 64 (35%) 28 (17%) 
Religion – Hindu 2 (.2%) 1 (.2%) 0 0 1 (.6%) 
Religion – Atheist 1 (.1%) 1 (.2%) 0 0 0 
Religion – Muslim 1 (.1%) 0 1 (.4%) 0 0 
Religion – Universal 3 (.3%) 0 2 (.9%) 1 (.6%) 0 
Payer – 











Payer – Medicaid 64 (6%) 20 (5%) 17 (8%) 15 (8%) 12 (7%) 
























Payer – Private Pay 13 (1%) 5 (2%) 3 (1%) 5 (3%) 0 
Reside – 











Reside - Houston Area 220 (22%) 35 (8%) 17 (8%) 14 (8%) 154 (91%) 
Reside - Austin Area 194 (19%) 89 (21%) 8 (4%) 94 (52%) 3 (2%) 
Reside – 











Reside - Waco Area 115 (11%) 95 (22%) 4 (2%) 11 (6%) 1 (.6%) 










Reside - North & West 
Texas 










Reside - Outside Texas 9 (1%) 2 (.4%) 3 (1%) 3 (2%) 1 (.6%) 
a: Missing Data   OOC: Opioid of Choice   STR: Short-term Residential   
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Table 2 
Mann-Whitney U Results 
LOS: Length of Stay   STR: Short-term Residential 
 
 
 Mann-Whitney U for 
STR Completion 
Sig. Mann-Whitney U for 
Detox Prior to STR 
Sig. 
Combined Sites     
Age in Years 121820.500 .550 92107.500 .381 
Age First Use  113742.000 .286 86139.000 .254 
Detox LOS 113005.000 .010 514.000 <.001 
# of Prior Detox or STR 119457.500 .060 94714.000 .737 
Frequency Last 30 Days 108208.500 .005 56879.500 <.001 











Table 3 – Pearson Chi-Square Crosstabulations 
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Table 3 
Pearson Chi-Square Crosstabulations 
 Pearson Chi-Square 
with STR Completion 
Sig. Pearson Chi-Square with 
Detox Prior to STR 
Sig. 
Combined Sites     
Treatment Location 9.428 .024 37.585 <.001 
Gender 11.483 .001 .178 .673 
Race .669 .995 4.424 .619 
Opioid of Choice 8.268 .041 10.767 .013 
Route 8.606 .035 6.831 .077 
Legal Classification 4.868 .301 13.118 .011 
Marital Status 4.163 .384 7.591 .108 
Veteran Status 1.073 .300 1.086 .297 
Employment Status 8.482 .014 1.111 .574 
Religion 7.381 .496 8.291 .406 
Payer Type 6.843 .233 47.063 <.001 
Geographic Region 10.579 .158 16.035 .025 















Table 4 – Binomial Logistic Regression Results – Demographic and 
Drug Use History: Combined Treatment Sites 
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Table 4 
Binomial Logistic Regression Results –  














Treatment Location       
Site 1 (Index)  .025   .016  
Site 2 1.495 .017 [1.076, 2.077] 1.497 .041 [1.016, 2.206] 
Site 3 .936 .709 [.661, 1.326] .337 .042 [.118, .962] 
Site 4 .853 .384 [.597, 1.219] 1.573 .185 [.806, 3.070] 
Gender (Male) 1.546 .001 [1.201. 1.989] 1.689 .002 [1.280, 3.989] 
Age in Years 1.005 .496 [.991, 1.018] 1.009 .336 [.991, 1.028] 
Opioid of Choice       
Heroin (Index)  .046   .153  
Stronger than Morphine 
(MME) 
.928 .691 [.644, 1.339] 1.078 .862 [.464, 2.504] 
Equal to Morphine 
(MME) 
1.296 .073 [.976, 1.721] 1.527 .361 [616, 3.784]] 
Weaker than Morphine 
(MME) 
.452 .072 [.190, 1.074] .380 .241 [.075, 1.918] 
Frequency Last 30 
Days 
.986 .021 [.974, .998] .984 .051 [.969, 1.000] 
Number of Prior 
Treatments 
.861 .236 [.672, 1.103] .741 .155 [.490, 1.120] 
Route       
IV Injection (Index)  .037   .124  
Oral 1.246 .101 [.958, 1.620] .826 .664 [.349, 1.956] 
Nasal 2.031 .007 [1.217, 3.391] 2.342 .022 [1.129, 4.856] 
Smoking .996 .992 [.423, 2.343] .931 .912 [.261, 3.316] 
Employment       
Unemployed (Index)  .019   .135  
Employed Full-time 2.815 .005 [1.359, 5.831] 2.132 .049 [1.002, 4.538] 
Employed Part-time 1.320 .670 [.369, 4.724] 1.383 .660 [.991, 1.028] 
STR: Short-term Residential 
  











Table 5 – Binomial Logistic Regressions for STR Completion –  
Detoxification as Main Predictors



































Proposal Application – The Committee for the Protection Of Human Subjects at 
The University of Texas Health Science Center at Houston 
  













































































































































































Proposal Acceptance Letter - The Committee for the Protection Of Human 
Subjects at the University of Texas Health Science Center at Houston 
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